Clinically useful and cost-effective tools for the cytogenetics community
Total Trials
1
As Lead Sponsor
As Collaborator
0
NCT04541550
Allogeneic Micronized Amniotic Membrane Product for the Treatment of Hidradenitis Suppurativa
Phase: Phase 1
Role: Lead Sponsor
Start: Apr 1, 2021
Completion: Jul 1, 2021
Loading map...